1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow HieraBio Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy HB1011 (Allogeneic Myocardium-derived Mesenchymal Stem Cells) - Ischemic Cardiomyopathy | Phase 1 | Recruiting | HieraBio Inc. | 12 | 2026-06-23 | 2026-10-06 |
Heart Failure (1)
South Korea (1)